NCT01412762 Measuring Patient Expectations for Thyroid Surgery Status ACTIVE_NOT_RECRUITING Phase N/A
NCT01403324 Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer Status TERMINATED Phase NA
NCT01398085 IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT01392222 Treatment Decision-Making Among Patients Diagnosed With Papillary Microcarcinoma and Their Significant Others Status COMPLETED Phase N/A
NCT01384786 The Incidence of Thyroid Cancer in 4474 Patients Treated for Hyperthyroidism or Goiter Status COMPLETED Phase N/A
NCT01374659 Diagnostic Utility of [18F]-FDG-PET/CT and [124I]-PET/CT for Detection of Recurrence in Differentiated Thyroid Carcinoma Status UNKNOWN Phase N/A
NCT01325857 Analgesic Efficacy of Bilateral Superficial Cervical Plexus Block in Robot-assisted Endoscopic Thyroidectomy Using a Transaxillary Approach Status COMPLETED Phase NA
NCT01321554 A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Trial of Lenvatinib (E7080) in 131I-Refractory Differentiated Thyroid Cancer (DTC) Status COMPLETED Phase PHASE3
NCT01307761 An Easy Sonographic Scoring System for Predicting Malignant Thyroid Nodules Status UNKNOWN Phase N/A
NCT01270321 Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer Status COMPLETED Phase PHASE2
NCT01265381 Thyroid Cancer Among Chornobyl Clean-up Workers in Ukraine: Pilot Study Status TERMINATED Phase N/A
NCT01153945 Association Between Cancer Cells and Normal Versus (Vs.) Low Levels of Thyroid Hormones in the Serum Status WITHDRAWN Phase N/A
NCT01141309 Evaluating the Combination of Everolimus and Sorafenib in the Treatment of Thyroid Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01089335 Sentinel Lymphnode in Patients With Papillary Thyroid Carcinoma and in Patients With Suspected Thyroid Neoplasia Status COMPLETED Phase N/A
NCT01083550 Decision Making on Radioactive Iodine Treatment for Papillary Thyroid Cancer Status COMPLETED Phase PHASE2/PHASE3
NCT01074684 Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer Status COMPLETED Phase N/A